The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of langerhans cell homeostasis

Blood

Volumn 123, Issue 2, 2014, Pages 217-227

  Sparber, Florian ^a   Scheffler, Julia M ^a   Amberg, Nicole ^b   Tripp, Christoph H ^a   Heib, Valeska ^a   Hermann, Martin ^c   Zahner, Sonja P ^d   Clausen, Björn E ^d,e   Reizis, Boris ^f   Huber, Lukas A ^b   Stoitzner, Patrizia ^a   Romani, Nikolaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLYCOPROTEIN P 15095; LYSOSOMAL ADAPTOR AND MITOGEN ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR REGULATOR 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; HOMEOSTASIS; IN VIVO STUDY; LANGERHANS CELL; LYSOSOME MEMBRANE; METAPHASE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHASE; SIGNAL TRANSDUCTION; TELOPHASE;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11C; APOPTOSIS; CELL PROLIFERATION; ENDOSOMES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HOMEOSTASIS; LANGERHANS CELLS; MICE; MICE, KNOCKOUT; MITOSIS; MULTIPROTEIN COMPLEXES; PROTEINS; SIGNAL TRANSDUCTION; SKIN; TOR SERINE-THREONINE KINASES;

EID: 84892655317     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-08-518555     Document Type: Article

References (40)

1. Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med. 2007;13(1):38-45. (Pubitemid 46067384)
2. Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 1996; 382(6588):262-265. (Pubitemid 26251362)
3. Nagle DL, Karim MA, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet. 1996;14(3):307-311. (Pubitemid 126449765)
4. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999;3(1):11-21. (Pubitemid 29292473)
5. Jung J, Bohn G, Allroth A, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood. 2006;108(1):362-369. (Pubitemid 43990650)
6. Wunderlich W, Fialka I, Teis D, et al. A novel 14-kilodalton protein interacts with the mitogenactivated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J Cell Biol. 2001;152(4):765-776. (Pubitemid 34280161)
7. Teis D, Wunderlich W, Huber LA. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell. 2002;3(6):803-814. (Pubitemid 35460781)
8. Nada S, Hondo A, Kasai A, et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J. 2009;28(5):477-489.
9. Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell. 2012; 150(6):1196-1208.
10. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141(2):290-303.
11. Magee J, Cygler M. Interactions between kinase scaffold MP1/p14 and its endosomal anchoring protein p18. Biochemistry. 2011;50(18): 3696-3705.
12. Teis D, Taub N, Kurzbauer R, et al. p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol. 2006;175(6):861-868. (Pubitemid 44969192)
13. Prokudin I, Stasyk T, Rainer J, Bonn GK, Kofler R, Huber LA. Comprehensive proteomic and transcriptomic characterization of hepatic expression signatures affected in p14 liver conditional knockout mice. Proteomics. 2011; 11(3):469-480.
14. Taub N, Nairz M, Hilber D, Hess MW, Weiss G, Huber LA. The late endosomal adaptor p14 is a macrophage host-defense factor against Salmonella infection. J Cell Sci. 2012;125(Pt 11): 2698-2708.
15. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012;30:1-22.
16. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563-604.
17. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev. 2010;234(1): 120-141.
18. Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity. 2012;36(5):873-884.
19. Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654. (Pubitemid 40719199)
20. -dendritic cells in the spleen. J Exp Med. 2007; 204(7):1653-1664. (Pubitemid 47048031)
21. Zahner SP, Kel JM, Martina CA, Brouwers-Haspels I, van Roon MA, Clausen BE. Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity. J Immunol. 2011; 187(10):5069-5076.
22. Stoitzner P, Romani N, McLellan AD, Tripp CH, Ebner S. Isolation of skin dendritic cells from mouse and man. Methods Mol Biol. 2010;595: 235-248.
23. Madisen L, Zwingman TA, Sunkin SM, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13(1):133-140.
24. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol. 2002;3(12):1135- 1141. (Pubitemid 35469697)
25. Chang-Rodriguez S, Hoetzenecker W, Schwärzler C, Biedermann T, Saeland S, Elbe-Bürger A. Fetal and neonatal murine skin harbors Langerhans cell precursors. J Leukoc Biol. 2005; 77(3):352-360. (Pubitemid 40289565)
26. Chorro L, Sarde A, Li M, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med. 2009;206(13):3089-3100.
27. Hendzel MJ, Wei Y, Mancini MA, et al. Mitosisspecific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma. 1997;106(6): 348-360. (Pubitemid 27510848)
28. Nagao K, Kobayashi T, Moro K, et al. Stressinduced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol. 2012;13(8):744-752.
29. Seré K, Baek J-H, Ober-Blöbaum J, et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity. 2012;37(5):905-916.
30. Weinlich G, Heine M, Stössel H, et al. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J Invest Dermatol. 1998;110(4):441-448. (Pubitemid 28158664)
31. de Araújo MEG, Stasyk T, Taub N, et al. Stability of the endosomal scaffold protein LAMTOR3 depends on heterodimer assembly and proteasomal degradation. J Biol Chem. 2013; 288(25):18228-18242.
32. Borkowski TA, Letterio JJ, Mackall CL, et al. A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest. 1997;100(3):575-581. (Pubitemid 27340504)
33. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med. 2007; 204(11):2545-2552. (Pubitemid 350044780)
34. Greter M, Lelios I, Pelczar P, et al. Stromaderived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 2012;37(6): 1050-1060.
35. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol. 2012;13(8):753-760.
36. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003; 19(1):71-82. (Pubitemid 36859902)
37. Liu K, Victora GD, Schwickert TA, et al. In vivo analysis of dendritic cell development and homeostasis. Science. 2009;324(5925):392-397.
38. Tripp CH, Chang-Rodriguez S, Stoitzner P, et al. Ontogeny of Langerin/CD207 expression in the epidermis of mice. J Invest Dermatol. 2004; 122(3):670-672. (Pubitemid 38471335)
39. Kellersch B, Brocker T. Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. Blood. 2013;121(2): 298-307.
40. Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(Pt 20):3589-3594.